HAYA THERAPEUTICS
HAYA Therapeutics is a developer of RNA-based therapeutics created to treat heart failure. The company's therapeutics utilizes biopharmaceutical therapy to target a heart specific regulator of fibrosis, the long noncoding RNA, enabling physicians to to block myocardial fibrosis and treat heart failure.
HAYA THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2017-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.hayatx.com
Total Employee:
1+
Status:
Active
Total Funding:
25.33 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag Mobile Non Scaleable Content Cloudflare JS CDN JS AJAX Libraries API
Current Advisors List
Board_member
Board_member
Board_member
2021-05-20
Board_member
2021-05-20
Current Employees Featured
Daniel Blessing Co-Founder and Chief Technology Officer @ HAYA Therapeutics
Co-Founder and Chief Technology Officer
Samir Ounzain Co-founder and Chief Executive Officer @ HAYA Therapeutics
Co-founder and Chief Executive Officer
Founder
Investors List
Viva BioInnovator
Viva BioInnovator investment in Seed Round - HAYA Therapeutics
Humboldt Fund
Humboldt Fund investment in Seed Round - HAYA Therapeutics
Apollo Health Ventures
Apollo Health Ventures investment in Seed Round - HAYA Therapeutics
Bernina BioInvest
Bernina BioInvest investment in Seed Round - HAYA Therapeutics
Schroder Adveq
Schroder Adveq investment in Seed Round - HAYA Therapeutics
4See Ventures
4See Ventures investment in Seed Round - HAYA Therapeutics
Broadview Ventures
Broadview Ventures investment in Seed Round - HAYA Therapeutics
Apollo Health Ventures
Apollo Health Ventures investment in Seed Round - HAYA Therapeutics
Schroder Adveq
Schroder Adveq investment in Seed Round - HAYA Therapeutics
Bernina BioInvest
Bernina BioInvest investment in Seed Round - HAYA Therapeutics
Official Site Inspections
http://www.hayatx.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "HAYA Therapeutics"
HAYA Therapeutics - Crunchbase Company Profile
HAYA Therapeutics is a biopharmaceutical company that specializes in treating heart failure diseases.See details»
HAYA Therapeutics | Precision Medicines Targeting the Dark …
Info@hayatx.com. San Diego. HAYA Therapeutics Inc. 4755 Nexus Center Drive Suite 1 San Diego California 92121 United States. info@hayatx.com. Precision Medicines Targeting the …See details»
Greg Smith | Senior Director, Human Resources | HAYA Therapeutics
Info@hayatx.com. San Diego. HAYA Therapeutics Inc. 4755 Nexus Center Drive Suite 1 San Diego California 92121 United States. info@hayatx.com. ... international growth by designing …See details»
Benjamin Kreitman | Director | HAYA Therapeutics - hayatx.com
Info@hayatx.com. Board of Directors. Benjamin Kreitman. Director. Meet Benjamin. Benjamin Kreitman broadly supports the Broadview investment team in its day-to-day operations, …See details»
HAYA Therapeutics Establishes U.S. Location - hayatx.com
For more information on the company, please visit our website at www.hayatx.com. Follow us on Twitter and LinkedIn. About Humboldt Fund. Humboldt Fund is a VC firm focused on …See details»
HAYA Therapeutics Appoints Former Exscientia Executive Dr.
Mar 13, 2025 For more information on the company, please visit our website at www.hayatx.com. Follow us on X and LinkedIn. Media Contact: Tim Ingersoll Email: …See details»
Haya Therapeutics - CB Insights
Hayatx.com. Overview & Products; Financials; People; Total Raised $28.54M. Investors Count 16. Funding, Valuation & Revenue. 13 Fundings. Haya Therapeutics has raised $28.54M over 13 …See details»
HTX-001 (Haya Therapeutics) - life-sciences-europe.com
Jul 1, 2024 HAYA’s mission is to identify and develop breakthrough disease-modifying therapeutics with the potential for greater efficacy, safety, and accessibility than existing …See details»
HAYA Therapeutics | HAYA Therapeutics Announces Collaboration …
Sep 4, 2024 LAUSANNE, Switzerland and SAN DIEGO, USA – Sept. 4, 2024 – HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory …See details»
HTX-001 Drug Profile - Ozmosi
HTX-001 Alternative Names: HTX-001, HTX001 Latest Update: 2025-03-13 Latest Update Note: News ArticleSee details»
Daniel Blessing - HAYA Therapeutics | LinkedIn - LinkedIn Schweiz
Experience: HAYA Therapeutics · Education: Université de Lausanne · Location: Lausanne · 500+ connections on LinkedIn. View Daniel Blessing’s profile on LinkedIn, a professional community of 1 billion members.See details»
HAYA Therapeutics Appoints Former Exscientia Executive Dr.
Mar 13, 2025 "When I looked at HAYA, I saw a company that is not only the first to fully understand how to map these regulatory areas of the human genome to disease but is also …See details»
HAYA Therapeutics Appoints Former Exscientia Executive Dr.
Mar 13, 2025 Dr. Richard Law, a former Exscientia executive who helped build the company and facilitate its merger with Recursion Pharmaceuticals, is joining HAYA Therapeutics as Chief …See details»
69 Best Life Science Startups to Watch in 2025
Daniel Blessing *****@hayatx.com; ProNAi Therapeutics. 2. Funding Rounds. $71.5m. Money raised. Now known as Sierra Oncology, is a clinical stage drug development company in …See details»
69 Best Biotech Startups in Switzerland to Watch in 2025 - Seedtable
Feb 18, 2025 Daniel Blessing *****@hayatx.com; Scioderm. 1. Funding Rounds. $16.0m. Money raised. A pharmaceutical company that develops topical products to treat rare diseases . ...See details»
7 Organizational Structure Types (With Examples) - Forbes
May 29, 2024 A hierarchical organization structure is the pyramid-shaped organization chart many people are used to seeing. There is one role at the top of the pyramid and the chain of …See details»
10亿美元！礼来投资HAYA Therapeutics，看好新型肥胖药物RNA …
Sep 5, 2024 后台 回复“ 资料 ”， 生物医药资料大合集，限时领取. 礼来（Eli Lilly）对肥胖领域的探索，已踏入了基因组学的未知领域。 美东时间9月4日， HAYA Therapeutics 宣布与礼来达 …See details»
HAYA Therapeutics Appoints Former Exscientia Executive Dr.
Mar 13, 2025 Dr. Richard Law, a former Exscientia executive who helped build the company and facilitate its merger with Recursion Pharmaceuticals, is joining HAYA Therapeutics as Chief …See details»
HAYA Therapeutics | HAYA Therapeutics Completes CHF 18
Info@hayatx.com. San Diego. HAYA Therapeutics Inc. 4755 Nexus Center Drive Suite 1 San Diego California 92121 United States. info@hayatx.com. Press Release. HAYA Therapeutics …See details»
69 Best Startups in Switzerland to Watch in 2025 - Seedtable
Feb 18, 2025 Daniel Blessing *****@hayatx.com; FQX. 3. Funding Rounds. $6.7m. Money raised. FQX is radically facilitating trade finance & money markets by using eNotes™ ... Boomerang is an organization that provides electronic mail and supports Microsoft exchange for clients. Industries: Productivity software Software Email. Location:See details»